Diamedica Therapeutics Inc (DMAC)

04:20 AM

What is the risk reward ratio of investing in DiaMedica Therapeutics Inc. stockBuild wealth with high-performing stocks - jammulinksnews.com

04:20 AM

12:34 PM

What are the technical indicators suggesting about DiaMedica Therapeutics Inc.Consistent high-performance stocks - jammulinksnews.com

12:34 PM

11:41 AM

What are analysts’ price targets for DiaMedica Therapeutics Inc. in the next 12 monthsPowerful growth strategies - jammulinksnews.com

11:41 AM

11:11 AM

What are the latest earnings results for DiaMedica Therapeutics Inc.Build wealth steadily with proven stock picks - jammulinksnews.com

11:11 AM

09:03 AM

Intrinsic Value of DiaMedica Therapeutics Inc. Stock: Is It Undervalued or OvervaluedSafer Investing With Bigger Upside - Newser

09:03 AM

08:26 AM

What makes DiaMedica Therapeutics Inc. stock price move sharplyBreakout Setup Scanner - Newser

08:26 AM

07:38 AM

Is DiaMedica Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis InsideFree Stock Market Return Analysis - Newser

07:38 AM

Jul 26, 2025

DiaMedica therapeutics (DMAC): Trill AB buys $5.4m in shares By Investing.com - Investing.com South Africa

Jul 26, 2025

Jul 26, 2025

DiaMedica therapeutics (DMAC): Trill AB buys $5.4m in shares - Investing.com

Jul 26, 2025

Jul 26, 2025

DiaMedica therapeutics (DMAC) shareholder TomEnterprise Private AB buys $10M in stock - Investing.com

Jul 26, 2025

Jul 26, 2025

DiaMedica Therapeutics Stock (DMAC) Opinions on $30 Million Private Placement - Quiver Quantitative

Jul 26, 2025

Jul 25, 2025

What drives DiaMedica Therapeutics Inc. stock priceRapidly growing investment returns - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Ischemic Stroke Pipeline Experiences Rapid Expansion as Over 50+ Leading Companies Advance Novel Therapies - The Globe and Mail

Jul 25, 2025

Jul 25, 2025

DiaMedica gains on positive mid-stage trial data for lead drug in preeclampsia - MSN

Jul 25, 2025

Jul 25, 2025

DiaMedica Therapeutics Inc. Stock Analysis and ForecastFree Market Volatility Navigation Tips - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Is DiaMedica Therapeutics Inc. a good long term investmentMarket-crushing stock picks - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Is DiaMedica Therapeutics Inc. stock overhyped or has real potentialBreakthrough financial growth - jammulinksnews.com

Jul 25, 2025

Jul 24, 2025

DiaMedica raises $30.1M in private placement for preeclampsia, stroke treatment - The Business Journals

Jul 24, 2025

Jul 24, 2025

The Beat: Entrust names new CEO, DiaMedica raises millions - The Business Journals

Jul 24, 2025

Jul 24, 2025

DiaMedica Therapeutics Announces Closing of $30.1 Million Private Placement - BioSpace

Jul 24, 2025

Jul 23, 2025

DiaMedica Therapeutics Secures $30.1 Million in Private Placement - TipRanks

Jul 23, 2025

Jul 23, 2025

DiaMedica Therapeutics closes $30.1 million private placement - Investing.com India

Jul 23, 2025

Jul 23, 2025

DiaMedica Therapeutics closes $30.1 million private placement By Investing.com - Investing.com UK

Jul 23, 2025

Jul 22, 2025

What analysts say about DiaMedica Therapeutics Inc. stockFree Stock Market Knowledge Sharing - jammulinksnews.com

Jul 22, 2025

Jul 21, 2025

Diamedica Therapeutics shares rise 11.01% intraday after $30.1M private placement and positive trial results for DM199 in preeclampsia. - AInvest

Jul 21, 2025

Jul 21, 2025

DiaMedica Therapeutics to sell 8.606M shares at $3.50 in private placement - TipRanks

Jul 21, 2025

Jul 21, 2025

DiaMedica Announces $30.1M Private Placement for DM199 - TipRanks

Jul 21, 2025

Jul 21, 2025

DiaMedica secures $30.1 million in private placement for clinical trials - Investing.com Australia

Jul 21, 2025

Jul 21, 2025

DiaMedica secures $30.1 million in private placement for clinical trials By Investing.com - Investing.com South Africa

Jul 21, 2025

Jul 21, 2025

DiaMedica Therapeutics Raises $30 Million in Private Placement to Accelerate Industry Leading Preeclampsia and Fetal Growth Restriction Pipeline - Business Wire

Jul 21, 2025

Jul 21, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Given New $11.00 Price Target at Craig Hallum - MarketBeat

Jul 21, 2025

Jul 21, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Price Target Raised to $12.00 - Defense World

Jul 21, 2025

Jul 20, 2025

DiaMedica shares drop 35% following InvestingPro’s overvalued warning By Investing.com - Investing.com India

Jul 20, 2025

Jul 18, 2025

DiaMedica stock price target raised to $12 from $10 at H.C. Wainwright - Investing.com Nigeria

Jul 18, 2025

Jul 17, 2025

DiaMedica Therapeutics to be included in the Russell 2000 and 3000 indexes - MSN

Jul 17, 2025

Jul 17, 2025

DiaMedica Therapeutics Reports Positive Interim Phase 2 Preeclampsia Results: Statistically Significant Reductions in Blood Pressure and No Placental Transfer - BioSpace

Jul 17, 2025

Jul 17, 2025

DiaMedica Therapeutics reports interim results from DM199 study - TipRanks

Jul 17, 2025

Jul 17, 2025

DiaMedica Announces Positive Interim Results for DM199 Study - TipRanks

Jul 17, 2025